OTC drug private label giant Perrigo Co. PLC will change its focus from health care to "self care" and compete outside its core sector to solve its revenue problems, says recently appointed CEO Murray Kessler.
During Perrigo's 2018 third-quarter earnings briefing Nov. 8, Kessler also said the firm's Rx generics business will see some changes even as Perrigo still looks to sell it or spin it off
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?